病灶内注射利妥昔单抗治疗原发性虹膜淋巴瘤。 - Suppr

Suppr

超能文献

Intralesional rituximab for primary iris lymphoma.

作者信息

Demirci Hakan, Grant Joshua S, Elner Victor M

机构信息

Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor.

出版信息

JAMA Ophthalmol. 2015 Jan;133(1):104-5. doi: 10.1001/jamaophthalmol.2014.3303.

DOI:10.1001/jamaophthalmol.2014.3303

PMID:25211092

Abstract

摘要

相似文献

Intralesional rituximab for primary iris lymphoma.

JAMA Ophthalmol. 2015 Jan;133(1):104-5. doi: 10.1001/jamaophthalmol.2014.3303.

Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.

Ophthalmology. 2011 Jan;118(1):24-8. doi: 10.1016/j.ophtha.2010.04.036. Epub 2010 Aug 14.

Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma.

JAMA Ophthalmol. 2015 Aug;133(8):969-70. doi: 10.1001/jamaophthalmol.2015.1153.

Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma—Reply.

JAMA Ophthalmol. 2015 Aug;133(8):970. doi: 10.1001/jamaophthalmol.2015.1167.

Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.

J AAPOS. 2018 Apr;22(2):159-161. doi: 10.1016/j.jaapos.2017.10.016. Epub 2018 Apr 3.

[Abdominal pain and rectorrhage in a 68-year-old woman].

Med Clin (Barc). 2005 Apr 23;124(15):588-94. doi: 10.1157/13074143.

Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.

Leuk Res. 2009 Sep;33(9):e154-6. doi: 10.1016/j.leukres.2009.03.026. Epub 2009 Apr 21.

Mantle cell lymphoma of the iris.

Acta Ophthalmol Scand. 2007 May;85(3):341-3. doi: 10.1111/j.1600-0420.2006.00845.x.

Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.

Ann Oncol. 2013 Sep;24(9):2434-8. doi: 10.1093/annonc/mdt181. Epub 2013 May 26.

Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): a case report and review of the literature.

Med Oncol. 2012 Jun;29(2):1223-6. doi: 10.1007/s12032-011-9955-3. Epub 2011 Jul 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Intralesional rituximab for primary iris lymphoma.

作者信息

Demirci Hakan, Grant Joshua S, Elner Victor M

机构信息

Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor.

出版信息

JAMA Ophthalmol. 2015 Jan;133(1):104-5. doi: 10.1001/jamaophthalmol.2014.3303.

DOI:10.1001/jamaophthalmol.2014.3303

PMID:25211092

Abstract

摘要

相似文献

Intralesional rituximab for primary iris lymphoma.

JAMA Ophthalmol. 2015 Jan;133(1):104-5. doi: 10.1001/jamaophthalmol.2014.3303.

Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.

Ophthalmology. 2011 Jan;118(1):24-8. doi: 10.1016/j.ophtha.2010.04.036. Epub 2010 Aug 14.

Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma.

JAMA Ophthalmol. 2015 Aug;133(8):969-70. doi: 10.1001/jamaophthalmol.2015.1153.

Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma—Reply.

JAMA Ophthalmol. 2015 Aug;133(8):970. doi: 10.1001/jamaophthalmol.2015.1167.

Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.

J AAPOS. 2018 Apr;22(2):159-161. doi: 10.1016/j.jaapos.2017.10.016. Epub 2018 Apr 3.

[Abdominal pain and rectorrhage in a 68-year-old woman].

Med Clin (Barc). 2005 Apr 23;124(15):588-94. doi: 10.1157/13074143.

Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.

Leuk Res. 2009 Sep;33(9):e154-6. doi: 10.1016/j.leukres.2009.03.026. Epub 2009 Apr 21.

Mantle cell lymphoma of the iris.

Acta Ophthalmol Scand. 2007 May;85(3):341-3. doi: 10.1111/j.1600-0420.2006.00845.x.

Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.

Ann Oncol. 2013 Sep;24(9):2434-8. doi: 10.1093/annonc/mdt181. Epub 2013 May 26.

Med Oncol. 2012 Jun;29(2):1223-6. doi: 10.1007/s12032-011-9955-3. Epub 2011 Jul 31.